Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta.

Luther JM, Wang Z, Ma J, Makhanova N, Kim HS, Brown NJ.

Endocrinology. 2009 May;150(5):2229-36. doi: 10.1210/en.2008-1296. Epub 2008 Dec 23.

2.

Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.

Brown NJ, Bradford J, Wang Z, Lea W, Ma L, Ma J, Vaughan DE, Fogo AB.

Kidney Int. 2007 Jul;72(1):72-81. Epub 2007 Apr 11.

3.

Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.

Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):365-71. Epub 2004 Dec 2.

4.

Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.

Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK.

Circulation. 2003 Nov 18;108(20):2517-23. Epub 2003 Oct 27.

5.

Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression.

Chen HC, Bouchie JL, Perez AS, Clermont AC, Izumo S, Hampe J, Feener EP.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2297-302.

6.

Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice.

Tsujino T, Naito Y, Kawasaki D, Okuda S, Sakoda T, Fujioka Y, Sugaya T, Ohyanagi M.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):159-68.

PMID:
15835378
7.

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.

Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB.

Kidney Int. 2000 Jul;58(1):251-9.

8.

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.

Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ.

Kidney Int. 2006 Mar;69(6):1064-72.

9.
10.

Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ.

Kidney Int. 2012 Sep;82(6):643-51. doi: 10.1038/ki.2012.170. Epub 2012 May 23.

11.

Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats.

Chun TY, Chander PN, Kim JW, Pratt JH, Stier CT Jr.

Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E305-12. doi: 10.1152/ajpendo.00512.2007. Epub 2008 May 20.

12.

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.

Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE.

J Clin Endocrinol Metab. 2000 Jan;85(1):336-44.

PMID:
10634408
13.

Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.

Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF.

J Hypertens. 2011 Aug;29(8):1602-12. doi: 10.1097/HJH.0b013e32834840e8.

PMID:
21610512
14.

Association of TGF-beta signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: role of PKC.

Motojima M, Kakuchi J, Yoshioka T.

Biochim Biophys Acta. 1999 Apr 1;1449(3):217-26.

15.

Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.

Gesualdo L, Ranieri E, Monno R, Rossiello MR, Colucci M, Semeraro N, Grandaliano G, Schena FP, Ursi M, Cerullo G.

Kidney Int. 1999 Aug;56(2):461-70.

16.

Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB.

Am J Pathol. 2003 Oct;163(4):1261-73.

17.

Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.

Sawathiparnich P, Murphey LJ, Kumar S, Vaughan DE, Brown NJ.

J Clin Endocrinol Metab. 2003 Aug;88(8):3867-73.

PMID:
12915681
18.
19.

Regulation of the myocardial endothelin system by angiotensin-II and losartan.

McEwan PE, Sherry L, Kenyon CJ, Webb DJ, Gray GA.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S144-7.

PMID:
11078361
20.

The mechanism of distinct diurnal variations of renin-angiotensin system in aorta and heart of spontaneously hypertensive rats.

Naito Y, Tsujino T, Matsumoto M, Okuda S, Sakoda T, Ohyanagi M, Masuyama T.

Clin Exp Hypertens. 2009 Nov;31(8):625-38. doi: 10.3109/10641960903406993.

PMID:
20001455

Supplemental Content

Support Center